Clinical Trials at University of Iowa Health Care
As of September 2026, 43 paid clinical trials are recruiting at University of Iowa Health Care in Iowa City, Iowa. Active studies at this site cover conditions such as Acute Myeloid Leukemia, Breast Cancer and Multiple Myeloma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Iowa City
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
44 clinical trials at University of Iowa Health Care
·Clear filters·A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
A Gaucher Disease Gene Therapy Trial With FLT201
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Myriad™ Augmented Soft Tissue Reconstruction Registry
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
Duchenne Electronic Health Record Study
Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma
Sitagliptin in Recurrent/Progressive Grade 4 Glioma
5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors
T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas
High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)
PERceptions of Diltiazem Versus ADEnosine for Treatment of Supraventricular Tachycardia in the Emergency Department
Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.
Adenosine vs Diltiazem for Treatment of SVT in the ED
Ketamine Alcohol (in Treatment-Resistant Depression)
IV vs Epidural Opioids + Epidural Local Anesthetic for Laparotomy Analgesia
Genetic Risk Factor for Heat Stroke
University of Iowa Interventional Psychiatry Service Patient Registry
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
SMBP Study: Improving High Blood Pressure in Older Adults With Multiple Chronic Diseases
The Heartland Study
Mirikizumab Real World Protocol
Objectively Diagnose and Monitor Treatment of Light Sensitivity
Outcomes of Limited Postoperative Restrictions Following Sling Placement: A Randomized Controlled Trial
Can PLIA Reduce Early Post-operative Pain After PAO Surgery?
Essential Amino Acid Supplementation for Femoral Fragility Fractures
Common conditions studied in Iowa City
- Acute Myeloid Leukemia (11 active studies)
- Breast Cancer (11 active studies)
- Multiple Myeloma (8 active studies)
- Hearing Loss, Sensorineural (5 active studies)
- Non-Hodgkin Lymphoma (5 active studies)
- Bladder Cancer (4 active studies)
Leading research sponsors in Iowa City
- University of Iowa
- National Cancer Institute (NCI)
- Children's Oncology Group
- Novartis Pharmaceuticals
- Anna Stanhewicz, PhD
Frequently asked questions
How many paid clinical trials are currently recruiting in Iowa City?
There are approximately 553 recruiting clinical trials in Iowa City, Iowa listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Iowa City pay participants?
Most recruiting trials in Iowa City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Iowa City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Iowa City?
The most common conditions under active study in Iowa City include Acute Myeloid Leukemia (11), Breast Cancer (11), Multiple Myeloma (8), Hearing Loss, Sensorineural (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Iowa City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Iowa City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Iowa City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Iowa City?
Recruiting research sites in Iowa City include University of Iowa, University of Iowa/Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Iowa City right now?
The largest active categories in Iowa City are Cancer & tumors (178), Neurology & pain (32), Cardiovascular (27). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.